Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features

Eur J Med Chem. 2022 Aug 5:238:114471. doi: 10.1016/j.ejmech.2022.114471. Epub 2022 May 20.

Abstract

To thoroughly investigate the uncharted chemical space around the entrance channel of HIV-1 reverse transcriptase (RT) and to improve the physicochemical properties, we introduced different spiro ring structures with high Fsp3 values as linkers at indole-2-carboxamide, attaching to various terminal substituents to enhance the interactions with the entrance channel. All the newly designed and synthesized indolylarylsulfone (IAS) derivatives exhibited moderate to excellent potency against wild-type HIV-1 with EC50 values ranging from 0.0053 to 0.19 μM. Among them, compounds SO-7g (EC50 = 0.0053 μM) and SO-7h (EC50 = 0.009 μM, SI > 21552) were identified as the most two potent compounds, which displayed 30- and 16-fold improvement than nevirapine and zidovudine and comparable potency to efavirenz and etravirine. Moreover, SO-7g maintained the promising activity against a variety of mutant strains, especially for L100I (EC50 = 0.047 μM), K103 N (EC50 = 0.056 μM), and E138K (EC50 = 0.040 μM). Notably, the introduction of spiro rings could effectively reduce the cytotoxicity (CC50) and greatly improve the selectivity index compared to lead compound, exemplified by SO-7h (CC50 > 214.4 μM, SI > 21552) and SO-7a (CC50 > 233.2 μM, SI > 20933). Additionally, the preliminary SARs based on antiviral activity and molecular simulation perspective were analyzed with a detailed description, which could point out the direction for further structural optimization.

Keywords: Drug design; Fsp(3); HIV-1; Indolylarylsulfone; NNRTIs; Spiro ring.

MeSH terms

  • Anti-HIV Agents* / chemistry
  • Anti-HIV Agents* / pharmacology
  • Drug Design
  • HIV Reverse Transcriptase / metabolism
  • HIV-1*
  • Molecular Structure
  • Reverse Transcriptase Inhibitors / chemistry
  • Reverse Transcriptase Inhibitors / pharmacology
  • Space Flight*
  • Structure-Activity Relationship

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • HIV Reverse Transcriptase